• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性性腺外生殖细胞肿瘤。临床表现、鉴别诊断及治疗]

[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy].

作者信息

Gerl A, Clemm C, Kohl P, Niedermaier J, Schalhorn A

机构信息

Medizinische Klinik III, Klinikum Grosshadern, Universität München.

出版信息

Med Klin (Munich). 1994 May 15;89(5):240-4.

PMID:7519720
Abstract

BACKGROUND

Primary extragonadal germ cell tumors are a rare malignant disease in young males. They account for only 1 to 4% of all germ cell tumors.

PATIENTS AND METHODS

In this paper we describe three selected cases of primary extragonadal germ cell tumors. The literature is reviewed with regard to clinical features, differential diagnosis and treatment.

RESULTS

Tumor markers alpha-fetoprotein and human chorionic gonadotropin are of considerable diagnostic value if disease distribution is considered. With cisplatin-based combination chemotherapy similar disease-free survival rates are achieved as for testicular tumors with poor-prognosis metastatic disease. Surgical procedures play a role as adjunctive modality.

CONCLUSIONS

If young males present with a mass in the retroperitoneum or in the anterosuperior mediastinum, a primary extragonadal germ cell tumor, should be taken into consideration. Tumors of both localisations have distinct clinical features but carry a similar prognosis. Patients benefit from the cumulative experience of a specialist unit.

摘要

背景

原发性性腺外生殖细胞肿瘤是年轻男性中一种罕见的恶性疾病。它们仅占所有生殖细胞肿瘤的1%至4%。

患者与方法

本文描述了3例原发性性腺外生殖细胞肿瘤的精选病例。对有关临床特征、鉴别诊断和治疗的文献进行了综述。

结果

如果考虑疾病分布,肿瘤标志物甲胎蛋白和人绒毛膜促性腺激素具有相当大的诊断价值。采用以顺铂为基础的联合化疗,可获得与预后不良的转移性睾丸肿瘤相似的无病生存率。手术作为辅助手段发挥作用。

结论

如果年轻男性出现腹膜后或前上纵隔肿块,应考虑原发性性腺外生殖细胞肿瘤。这两个部位的肿瘤具有不同的临床特征,但预后相似。患者受益于专科单位的累积经验。

相似文献

1
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy].[原发性性腺外生殖细胞肿瘤。临床表现、鉴别诊断及治疗]
Med Klin (Munich). 1994 May 15;89(5):240-4.
2
Poorly differentiated carcinoma and germ cell tumors.
Hematol Oncol Clin North Am. 1991 Dec;5(6):1223-31.
3
Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience.基于顺铂的原发性性腺外生殖细胞肿瘤化疗。单机构经验。
Cancer. 1996 Feb 1;77(3):526-32. doi: 10.1002/(SICI)1097-0142(19960201)77:3<526::AID-CNCR15>3.0.CO;2-6.
4
[Primary extragonadal germ cell tumors in men. 1. Frequency, morphology and clinical aspects].[男性原发性性腺外生殖细胞肿瘤。1. 发病率、形态学及临床特征]
Z Gesamte Inn Med. 1991 Apr;46(6):191-4.
5
[Retroperitoneal germ cell tumors with high level of serum and urine hCG in an adult: a case report].[成人血清和尿液人绒毛膜促性腺激素水平升高的腹膜后生殖细胞肿瘤:一例报告]
Hinyokika Kiyo. 1989 Feb;35(2):301-5.
6
Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.伴有肉瘤成分的生殖细胞肿瘤:46例临床病理及免疫组化研究
Am J Surg Pathol. 2007 Sep;31(9):1356-62. doi: 10.1097/PAS.0b013e318033c7c4.
7
Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.对一线化疗采用博来霉素、依托泊苷和顺铂治疗有良好反应的日本转移性生殖细胞肿瘤男性患者的预后分析。
Hinyokika Kiyo. 2007 Dec;53(12):851-6.
8
[Metachronous testicular tumor of an extragonadal germ cell tumor].[异时性性腺外生殖细胞肿瘤的睾丸肿瘤]
Aktuelle Urol. 2003 Oct;34(6):413-5. doi: 10.1055/s-2003-43170.
9
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.性腺外精原细胞瘤:预后因素及长期治疗结果的国际多中心分析
Cancer. 2001 Apr 1;91(7):1394-401.
10
Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.影响肿瘤标志物升高的化疗难治性生殖细胞癌患者挽救性手术结果的因素。
Cancer. 2003 Oct 15;98(8):1635-42. doi: 10.1002/cncr.11711.